BioRestorative Therapies BRTX
NASDAQ BRTX
$2.33 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Other financing activities (2024 - 2025)

Updated

BioRestorative Therapies' Other financing activities was $49,808 in Q4 2025, down 66.5% from $148,697 a year earlier and down 27.9% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Other financing activities (2024 - 2025) Analysis & Trends

  • Other financing activities shows a five-year compound annual growth rate of -37.0% (FY2020 to FY2025).
  • In earlier years, Other financing activities was $148,697 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioRestorative Therapies 1.03 Mn -22.90 Mn 17,964.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 49,808.00
Sep 30, 2025 69,066.00
Dec 31, 2024 148,697.00
API Access

BioRestorative Therapies Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BRTX&period=max&api_key=YOUR_API_KEY